Kodiak Sciences, Inc. (KOD)
37.56
-1.56
(-3.99%)
USD |
NASDAQ |
Aug 28, 11:57
Kodiak Sciences 1 Year Total Returns (Daily) : 318.8% for Aug. 27, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 27, 2026 | 318.8% |
| August 26, 2026 | 306.3% |
| August 25, 2026 | 316.7% |
| August 24, 2026 | 264.9% |
| August 21, 2026 | 294.7% |
| August 20, 2026 | 319.4% |
| August 19, 2026 | 322.7% |
| August 18, 2026 | 261.3% |
| August 17, 2026 | 287.7% |
| August 14, 2026 | 311.9% |
| August 13, 2026 | 363.8% |
| August 12, 2026 | 409.5% |
| August 11, 2026 | 424.4% |
| August 10, 2026 | 449.4% |
| August 07, 2026 | 453.3% |
| August 06, 2026 | 453.0% |
| August 05, 2026 | 439.1% |
| August 04, 2026 | 486.7% |
| August 03, 2026 | 498.9% |
| July 31, 2026 | 532.4% |
| July 30, 2026 | 482.2% |
| July 29, 2026 | 412.9% |
| July 28, 2026 | 389.0% |
| July 27, 2026 | 374.1% |
| July 24, 2026 | 401.9% |
| Date | Value |
|---|---|
| July 23, 2026 | 494.5% |
| July 22, 2026 | 651.3% |
| July 21, 2026 | 735.0% |
| July 20, 2026 | 640.4% |
| July 17, 2026 | 721.6% |
| July 16, 2026 | 771.2% |
| July 15, 2026 | 781.9% |
| July 14, 2026 | 736.8% |
| July 13, 2026 | 807.3% |
| July 10, 2026 | 820.0% |
| July 09, 2026 | 802.7% |
| July 08, 2026 | 941.8% |
| July 07, 2026 | 932.3% |
| July 06, 2026 | 837.2% |
| July 02, 2026 | 906.3% |
| July 01, 2026 | 890.4% |
| June 30, 2026 | 944.5% |
| June 29, 2026 | 920.0% |
| June 26, 2026 | 850.8% |
| June 25, 2026 | 823.8% |
| June 24, 2026 | 897.2% |
| June 23, 2026 | 920.7% |
| June 22, 2026 | 911.9% |
| June 18, 2026 | 923.8% |
| June 17, 2026 | 905.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 11.89% |
| Alnylam Pharmaceuticals, Inc. | -47.91% |
| Anika Therapeutics, Inc. | 127.0% |
| Savara, Inc. | 66.87% |
| Vericel Corp. | 14.74% |